Aloyz R - Search Results

1

Trastuzumab and vinorelbine in early stages of HER2-positive breast cancer.

Ferrario C, Wong A, Gao T, Bouganim N, Aloyz R, Panasci LC. Ferrario C, et al. Among authors: aloyz r. J Chemother. 2011 Feb;23(1):32-5. doi: 10.1179/joc.2011.23.1.32. J Chemother. 2011. PMID: 21482492

2

A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients.

Hebb J, Assouline S, Rousseau C, Desjardins P, Caplan S, Egorin MJ, Amrein L, Aloyz R, Panasci L. Hebb J, et al. Among authors: aloyz r. Cancer Chemother Pharmacol. 2011 Sep;68(3):643-51. doi: 10.1007/s00280-010-1530-7. Epub 2010 Dec 1. Cancer Chemother Pharmacol. 2011. PMID: 21120481 Clinical Trial.

3

The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines.

Davidson D, Wang Y, Aloyz R, Panasci L. Davidson D, et al. Among authors: aloyz r. Invest New Drugs. 2013 Apr;31(2):461-8. doi: 10.1007/s10637-012-9886-7. Epub 2012 Oct 9. Invest New Drugs. 2013. PMID: 23054213 Free PMC article.

4

PARP3 inhibitors ME0328 and olaparib potentiate vinorelbine sensitization in breast cancer cell lines.

Sharif-Askari B, Amrein L, Aloyz R, Panasci L. Sharif-Askari B, et al. Among authors: aloyz r. Breast Cancer Res Treat. 2018 Nov;172(1):23-32. doi: 10.1007/s10549-018-4888-6. Epub 2018 Jul 23. Breast Cancer Res Treat. 2018. PMID: 30039287

5

Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score.

Sahebjam S, Aloyz R, Pilavdzic D, Brisson ML, Ferrario C, Bouganim N, Cohen V, Miller WH Jr, Panasci LC. Sahebjam S, et al. Among authors: aloyz r. Br J Cancer. 2011 Oct 25;105(9):1342-5. doi: 10.1038/bjc.2011.402. Epub 2011 Oct 4. Br J Cancer. 2011. PMID: 21970880 Free PMC article.

6

Intrathecal trastuzumab and thiotepa for leptomeningeal spread of breast cancer.

Ferrario C, Davidson A, Bouganim N, Aloyz R, Panasci LC. Ferrario C, et al. Among authors: aloyz r. Ann Oncol. 2009 Apr;20(4):792-5. doi: 10.1093/annonc/mdp019. Epub 2009 Feb 17. Ann Oncol. 2009. PMID: 19223574 Free article. No abstract available.

7

Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitro.

Amrein L, Hernandez TA, Ferrario C, Johnston J, Gibson SB, Panasci L, Aloyz R. Amrein L, et al. Among authors: aloyz r. Br J Haematol. 2008 Dec;143(5):698-706. doi: 10.1111/j.1365-2141.2008.07418.x. Br J Haematol. 2008. PMID: 19062342 Free article.

8

Imatinib sensitizes CLL lymphocytes to chlorambucil.

Aloyz R, Grzywacz K, Xu ZY, Loignon M, Alaoui-Jamali MA, Panasci L. Aloyz R, et al. Leukemia. 2004 Mar;18(3):409-14. doi: 10.1038/sj.leu.2403247. Leukemia. 2004. PMID: 14712290

9

Homologous recombinational repair vis-à-vis chlorambucil resistance in chronic lymphocytic leukemia.

Bello VE, Aloyz RS, Christodoulopoulos G, Panasci LC. Bello VE, et al. Biochem Pharmacol. 2002 May 1;63(9):1585-8. doi: 10.1016/s0006-2952(02)00954-1. Biochem Pharmacol. 2002. PMID: 12007561

10

Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation, and reduced apoptosis.

Xu ZY, Loignon M, Han FY, Panasci L, Aloyz R. Xu ZY, et al. Among authors: aloyz r. J Pharmacol Exp Ther. 2005 Aug;314(2):495-505. doi: 10.1124/jpet.105.084053. Epub 2005 Apr 20. J Pharmacol Exp Ther. 2005. PMID: 15843498

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters